GE HealthCare Technologies

GE Healthcare is a multinational healthcare company based in Chicago, Illinois, that specializes in manufacturing a diverse range of medical equipment and technologies. Founded in 1892, the company offers products and services including medical imaging, information technologies, medical diagnostics, and patient monitoring systems. GE Healthcare also supports drug discovery and biopharmaceutical manufacturing through intelligent devices and data analytics. The company aims to enhance patient care and outcomes by providing innovative healthcare solutions utilized in hospitals, clinics, research institutions, and pharmaceutical companies globally. By focusing on precision health and digitizing healthcare, GE Healthcare seeks to improve productivity and health outcomes for patients and healthcare providers alike. Additionally, the company pursues an aggressive acquisition strategy to strengthen its presence in emerging markets and expand its life sciences portfolio.

Arnaud Marie

General Manager

Dagfinn Saetre

Executive

Thomas Westrick

President and CEO of Life Care Solutions

69 past transactions

Nihon Medi-Physics

Acquisition in 2024
Operates in the diagnostic nuclear medicine sector in Japan, developing and manufacturing radioactive pharmaceuticals and cancer therapies, with activities including research and development, production, importing and exporting radioactive medical devices, nuclear medicines, diagnostic agents and therapeutic drugs.

Molecular Assemblies

Grant in 2024
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.

Laza Medical

Series A in 2023
Laza Medical is a startup developing an AI-powered robotic imaging system for cardiovascular interventions. Its solution aims to optimize procedural workflows and enhance imaging standards in cardiac procedures, benefiting a wide range of clinicians.

Nucleus RadioPharma

Series A in 2023
Nucleus RadioPharma is a company focused on enhancing the accessibility of radiopharmaceuticals for cancer patients. It specializes in developing innovative technologies aimed at modernizing the clinical development, manufacturing, and supply chain processes associated with radiopharmaceutical therapies. By streamlining these aspects, Nucleus RadioPharma seeks to improve the delivery of novel treatments, thereby enabling healthcare professionals to more effectively diagnose and treat various cancer diseases.

MediView

Venture Round in 2023
MediView, LLC is a medical device company based in Cleveland, Ohio, that specializes in developing augmented reality surgical navigation systems aimed at enhancing surgical processes for healthcare providers. Founded in 2017, the company focuses on creating advanced technologies for surgical navigation, particularly for the ablation and biopsy of cancerous tumors. MediView's flagship product, MediView, utilizes real-time, fused-holographic visualization to enable surgeons to navigate procedures with greater accuracy and efficacy. This innovative approach allows for enhanced examination of patients through augmented reality 3D visualization, facilitating improved surgical outcomes and supporting remote collaboration among healthcare professionals.

Caption Health

Acquisition in 2023
Caption Health, Inc. is a technology company specializing in artificial intelligence software designed to enhance the acquisition and interpretation of ultrasound exams. Its flagship product, Caption AI, serves as an AI-guided medical imaging acquisition system that assists healthcare providers by offering real-time guidance, automating quality assessments, and interpreting ultrasound images to ensure diagnostic accuracy. Founded in 2013 and headquartered in Brisbane, California, Caption Health was previously known as Bay Labs, Inc. The company aims to scale its commercial operations and further develop its AI technology platform, intending to broaden the application of Caption AI across various clinical settings as adoption increases among healthcare practitioners.

Imactis

Acquisition in 2023
Imactis is a company focused on computer-assisted interventional radiology, dedicated to enhancing the efficiency and safety of minimally invasive needle procedures such as biopsies, tumor ablations, vertebroplasties, infiltrations, and drainages. The company develops and markets innovative solutions that assist interventional radiologists by improving accuracy, facilitating complex procedures, and reducing both the duration of interventions and the need for multiple controls. Its technology simplifies multi-needle alignment, provides real-time treatment planning, and enables medical professionals to navigate around critical structures without angular limitations. Through these advancements, Imactis aims to improve patient outcomes and overall care in medical institutions.

AliveCor

Series F in 2022
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.

Centerline Biomedical

Series B in 2022
Centerline Biomedical, Inc. is a Cleveland, Ohio-based company founded in 2014 that specializes in developing advanced surgical navigation technologies. The company focuses on an Intra-Operative Positioning System, which utilizes non-x-ray based three-dimensional GPS technology to enhance the precision of endovascular procedures and minimize radiation exposure for both patients and medical staff. Centerline's innovative system aids surgeons in navigating complex three-dimensional vascular anatomy, thereby improving surgical outcomes in interventional vascular procedures. The technology is rooted in advancements made at the Cleveland Clinic, reflecting a commitment to enhancing the safety and effectiveness of minimally invasive surgeries.

Pulsenmore

Post in 2022
Pulsenmore Ltd. is a company that specializes in the design and manufacture of handheld tele-ultrasound devices, enabling pregnant women to conduct ultrasound scans at home. Founded in 2015 and based in Omer, Israel, Pulsenmore's innovative ultrasound scanner connects to a patient's smartphone, allowing for high-quality imaging that can be created in any location. The device utilizes navigation and artificial intelligence tools to assist users during the scanning process. Additionally, Pulsenmore develops an application that facilitates the display, storage, and sharing of ultrasound images with healthcare professionals for remote feedback and clinical consultation. By providing a convenient and efficient alternative to traditional in-facility imaging, Pulsenmore is positioning itself as a leader in connected at-home ultrasound technology.

OhMD

Seed Round in 2022
OhMD, LLC is a New York-based company that specializes in developing a mobile messaging platform designed for direct communication between doctors and patients. This conversational patient engagement software enables HIPAA-compliant SMS and RCS text-based communication, streamlining interactions and enhancing the overall patient experience by eliminating the need for phone tag. By integrating seamlessly with electronic medical records, OhMD's platform allows healthcare providers to engage with patients using familiar technology, thereby improving satisfaction and fostering better health outcomes for the patient population. The company aims to empower care teams and patients with a reliable communication solution that supports effective healthcare delivery.

BK Medical Holding

Acquisition in 2021
BK Medical Holding is a manufacturer of advanced intraoperative imaging and surgical systems that enhance surgical precision through real-time image guidance. The company specializes in active imaging systems that utilize sophisticated ultrasound technology and software algorithms, providing surgeons with critical visual information during procedures. BK Medical's portable ultrasound scanners are designed specifically for use in surgery and urology, enabling medical professionals to make informed, data-driven decisions. This innovation not only improves clinical outcomes but also helps reduce costs for patients and the overall healthcare system, ultimately streamlining surgical processes and enhancing patient care.

CMR Surgical

Series D in 2021
CMR Surgical, established in 2014 and headquartered in Cambridge, UK, specializes in designing and manufacturing medical devices for minimal access surgery. The company's primary product is the Versius surgical robotic system, which facilitates laparoscopic surgery by providing surgeons with 3D high-definition imagery and feedback. CMR Surgical aims to make minimal access surgery universally accessible and affordable by expanding the range of procedures that can be performed using its robotic systems.

Zionexa

Acquisition in 2021
Zionexa is a global company focused on the development and commercialization of in-vivo biomarkers aimed at guiding targeted therapies in oncology. By leveraging advanced molecular imaging technology, Zionexa provides physicians with clear and detailed images that enhance the diagnosis of metastatic breast cancer. This innovative approach allows for the early identification of tumors and facilitates personalized patient care, improving the treatment pathway and overall quality of life for cancer patients. Through its commitment to advancing diagnostic capabilities, Zionexa plays a significant role in the evolving landscape of personalized medicine in oncology.

Prismatic Sensors

Acquisition in 2020
Prismatic Sensors AB specializes in the development of advanced photon counting detectors for medical x-ray imaging, with a focus on enhancing image quality while minimizing radiation exposure. Founded in 2012 as a spin-off from KTH Royal Institute of Technology in Stockholm, Sweden, the company leverages its expertise in electronics design, precision mechanics, and data acquisition programming to innovate in the field of medical imaging. Prismatic Sensors aims to improve patient selection for individualized treatment, contributing to better clinical outcomes. The company is experienced in system integration and navigating the regulatory approval process for its products, including prototype development for clinical trials. By transforming scientific research into practical applications, Prismatic Sensors supports healthcare professionals in making informed decisions, ultimately increasing patient survival rates.

Decisio Health

Series B in 2019
Decisio Health is a healthcare software company that delivers a clinical decision support platform designed to integrate real-time patient data from multiple sources into a single dashboard. The platform provides real-time monitoring, data visualization, and analytics that reveal a patient's status and trends, helping clinicians identify risk and make informed, timely treatment decisions at the point of care. By aggregating disparate data, it supports bedside decision-making, continuous monitoring, and adherence to protocols, while also enabling population surveillance and virtual care through telehealth. The solution is accessible via standard web browsers and aims to reduce time to intervention and close operational gaps for care teams. Founded in 2013 and based in Houston, Texas, Decisio Health focuses on delivering contextual insights to clinicians to improve patient outcomes.

SonoSim

Venture Round in 2018
SonoSim, Inc. is a company that specializes in ultrasound education and training services aimed at enhancing the skills of healthcare professionals and students in ultrasonography. Established in 2010 and based in Santa Monica, California, SonoSim offers a portable, laptop-based ultrasound training system that allows users to practice hands-on scanning at their convenience. Its flagship product, the SonoSim ultrasound training solution, provides on-demand access to patients, enabling physicians, diagnostic medical sonography students, nurses, and medical students to acquire and interpret sonographic images effectively. The company’s comprehensive education ecosystem supports a diverse clientele, including nursing schools, hospitals, and physician group practices, by integrating hands-on training with didactic instruction and assessment, ultimately improving the proficiency required for performing ultrasonography.

InSightec

Series E in 2017
InSightec Ltd. is a pioneering company based in Tirat Carmel, Israel, specializing in non-invasive medical treatments through its Exablate platform, which employs MR guided focused ultrasound technology. Founded in 1999, InSightec develops and distributes systems that address various oncology and gynecology conditions, including the Exablate Neuro for personalized thalamotomy in movement disorders and pain management. The Exablate system has received multiple regulatory approvals, including CE marks and FDA approval, for treatments of symptomatic uterine fibroids, pain from bone metastases, and adenomyosis. The company provides comprehensive support services, including onsite clinical training and maintenance, to medical professionals using its technology in facilities across Israel and internationally. InSightec maintains a strategic partnership with Lantheus Holdings and has expanded its presence in Europe, Asia, and the Americas, earning recognition for its innovative contributions to the field of acoustic surgery.

Puridify

Acquisition in 2017
Puridify Limited is a bioprocessing company based in Stevenage, United Kingdom, founded in 2013 by Tom Haywood, Oliver Hardick, and Iwan Roberts. The company specializes in developing advanced purification technologies for the manufacturing of industrial biomolecules. Its flagship product, FibroSelect, utilizes a unique nanofiber-based platform that enhances purification efficiency while addressing the limitations found in traditional packed bed chromatography systems. This innovative technology is designed to provide consistent purification performance across various scales, making it suitable for the purification of complex biotherapeutics, including gene therapies, viral vectors, and fusion proteins. By improving the efficiency and cost-effectiveness of biopharmaceutical production, Puridify aims to advance the industry and support the growing demand for high-quality biomolecule products.

Anfas Medical Care

Debt Financing in 2017
Anfas Medical Care is a specialized hospital focused on treating patients with long-term lung issues that require mechanical ventilation. The facility offers a comprehensive range of services, including respiratory therapy, intensive care, rehabilitation, clinical nutrition, palliative care, and urgent care. In addition to these core services, Anfas Medical Care provides laboratory services that encompass pre-analytical testing, clinical chemistry, immunology and serology, diagnostic microbiology, and blood products. The hospital is dedicated to enhancing the physical and mental well-being of its patients through tailored care and advanced medical support.

Novia Strategies

Acquisition in 2017
Novia Strategies, Inc. is a healthcare consulting firm based in Poway, California, founded in 1995. It specializes in providing consulting services to hospitals and healthcare systems, leveraging the expertise of clinicians and professionals in clinical, financial, and operational domains. The firm aims to assist healthcare organizations in transforming their operations to enhance quality and financial performance. By focusing on areas such as care management transformation, human resource staffing, and cost reductions, Novia Strategies enables its clients to improve patient care outcomes while effectively managing costs. As a subsidiary of The Camden Group since July 2017, Novia Strategies has evolved into a dynamic consultancy, committed to supporting healthcare providers in their mission to deliver care for future generations.

Asymptote

Acquisition in 2017
Asymptote Ltd. is a company based in Cambridge, United Kingdom, specializing in cryochain technology for advanced medicines, particularly sensitive cellular therapies. It designs and manufactures a comprehensive suite of cryochain hardware, software, and consumables aimed at maintaining the potency of cellular therapies during ultra-low temperature freezing and thawing processes. The company's product offerings include controlled rate freezers, automated thawing systems for cryobags and cryovials, and the my.Cryochain platform, which oversees the entire cryochain process. Additionally, Asymptote has developed IceStart, an innovative active nucleation material that minimizes damage caused by super cooling during cryopreservation. Its technologies are utilized in various fields, including regenerative medicine, biobanking, and food processing, ensuring that critical cellular therapies remain effective from production to patient administration. Asymptote Ltd. was incorporated in 1989 and operates as a subsidiary of GE Healthcare Limited.

Monica Healthcare

Acquisition in 2017
Monica Healthcare, based in Nottingham, United Kingdom, is a manufacturer of advanced fetal monitoring devices aimed at improving obstetric care. Founded in 2005, the company specializes in innovative wearable technologies that utilize wireless systems to monitor maternal heart rate, fetal heart rate, and uterine activity. One of its key products is The Novii, a single-use wireless patch designed for both hospital and home use. Monica Healthcare's devices are intended to enhance the birth experience for midwives, labor and delivery nurses, and expectant mothers, while also facilitating access to obstetric services. In addition to its product offerings, the company provides training, repairs, and support services to its customers. Since 2017, Monica Healthcare has been operating as a subsidiary of GE Healthcare.

Biosafe Group

Acquisition in 2016
Biosafe SA is a global medical technology company headquartered in the Lake Geneva region of Switzerland, established in 1997. It specializes in the development and manufacturing of automated cell processing systems, becoming a leading provider in the adult stem cell therapy sector. The company offers integrated cell bioprocessing solutions tailored for stem cell banks, hospitals, and research institutions, thereby establishing itself as an industry standard in cell therapy and regenerative medicine. Through its innovative technology, Biosafe supports advancements in the field, contributing to the growth and efficiency of cell processing procedures.

Caradigm

Acquisition in 2016
Caradigm is a provider of intelligent healthcare analytics and population health management solutions. The company specializes in enterprise population health management, visual analytics, and care management, along with a cloud-hosted intelligence platform. These services are designed to assist healthcare organizations in enhancing patient care, reducing costs, and effectively managing risk. By offering insights into patients, populations, and performance, Caradigm aims to empower healthcare entities to make informed decisions and improve overall health outcomes.

Adavium

Series C in 2016
Adavium Medical is a medical equipment and diagnostics company based in São Paulo, Brazil, established in 2011. The company focuses on commercializing an innovative portfolio of medical devices and diagnostic products, representing leading international manufacturers. With a workforce of over 300 employees, Adavium Medical operates a fully-integrated commercial platform that adheres to high standards. It boasts the largest customer base in Brazil, serving more than 2,500 clients in both premium and long-tail segments of the medical equipment and diagnostics market. This extensive reach significantly surpasses that of typical distributors and multinational companies in the region, positioning Adavium Medical as a key player in a fragmented industry.

The Camden Group

Acquisition in 2015
The Camden Group is a nationwide healthcare business advisory firm that helps hospitals, health systems, medical groups, outpatient facilities and other care delivery organizations transform their organizational, clinical and operational practices. The firm offers strategic and business planning, performance improvement, care model redesign and access optimization, physician compensation, mergers and acquisitions and other transactions, physician-hospital alignment, clinical integration, payer strategy, and the implementation of accountable care organizations. Founded in 1970, The Camden Group has advised more than 2,000 health systems, medical groups, hospitals, outpatient facilities, post-acute providers, and other healthcare organizations across the United States.

Gemedco Sales & Service

Acquisition in 2015
Gemedco Sales & Service is distributes diagnostic imaging equipment.

Omnyx

Acquisition in 2015
Omnyx, LLC is a joint venture between GE Healthcare and UPMC, located in Pittsburgh, PA, and Piscataway, NJ. The company specializes in digital pathology solutions designed to transition pathology departments to an all-digital workflow. Omnyx has developed the Omnyx IDP solution, which includes image acquisition devices, workflow software, and consulting services aimed at transforming cancer care. By closely collaborating with pathologists at UPMC and other institutions, Omnyx tailors its innovations to meet the needs of anatomic pathologists globally. Its products are designed for in vitro diagnostic use in specific clinical applications while being intended for research use in other areas. Omnyx's technology facilitates enhanced collaboration and streamlines case management, ultimately aiding medical organizations and cancer treatment centers in achieving effective cancer diagnoses and personalized patient care.

InSightec

Series D in 2014
InSightec Ltd. is a pioneering company based in Tirat Carmel, Israel, specializing in non-invasive medical treatments through its Exablate platform, which employs MR guided focused ultrasound technology. Founded in 1999, InSightec develops and distributes systems that address various oncology and gynecology conditions, including the Exablate Neuro for personalized thalamotomy in movement disorders and pain management. The Exablate system has received multiple regulatory approvals, including CE marks and FDA approval, for treatments of symptomatic uterine fibroids, pain from bone metastases, and adenomyosis. The company provides comprehensive support services, including onsite clinical training and maintenance, to medical professionals using its technology in facilities across Israel and internationally. InSightec maintains a strategic partnership with Lantheus Holdings and has expanded its presence in Europe, Asia, and the Americas, earning recognition for its innovative contributions to the field of acoustic surgery.

Check-Cap

Debt Financing in 2014
Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Isfiya, Israel, specializing in the development of innovative solutions for colorectal cancer screening. The company's flagship product, the C-Scan system, is a capsule-based technology that utilizes low-dose X-rays to detect colonic polyps and colorectal cancers without the need for bowel preparation or invasive procedures. The C-Scan system consists of three components: the C-Scan Cap, an ingestible capsule that collects and transmits imaging data; the C-Scan Track, a biocompatible device worn by the patient to track the capsule's movement and record data; and C-Scan View, software designed to process and visualize the captured clinical data. This preparation-free approach is intended to provide accuracy comparable to traditional colonoscopy, with the capsule passing naturally through the gastrointestinal tract. Check-Cap aims to bring its technology to markets in the United States, Europe, Israel, and Japan.

CHCA Computer Systems

Acquisition in 2014
CHCA Computer Systems specializes in computerized operating room management and analytics services within the healthcare sector. The company focuses on developing, integrating, and implementing information technology systems designed to enhance healthcare management. Among its key offerings is Concerto, an electronic health record system that enables real-time access to essential clinical information from any location. Additionally, CHCA provides Opera, an operating room management software application that supplies clinicians and administrators with vital information regarding surgical procedures. The company also features SUM, a measurement tool that aids in the assessment and optimization of operational efficiency in healthcare settings.

InSightec

Series C in 2012
InSightec Ltd. is a pioneering company based in Tirat Carmel, Israel, specializing in non-invasive medical treatments through its Exablate platform, which employs MR guided focused ultrasound technology. Founded in 1999, InSightec develops and distributes systems that address various oncology and gynecology conditions, including the Exablate Neuro for personalized thalamotomy in movement disorders and pain management. The Exablate system has received multiple regulatory approvals, including CE marks and FDA approval, for treatments of symptomatic uterine fibroids, pain from bone metastases, and adenomyosis. The company provides comprehensive support services, including onsite clinical training and maintenance, to medical professionals using its technology in facilities across Israel and internationally. InSightec maintains a strategic partnership with Lantheus Holdings and has expanded its presence in Europe, Asia, and the Americas, earning recognition for its innovative contributions to the field of acoustic surgery.

U-Systems

Acquisition in 2012
U-Systems is a developer and manufacturer of advanced ultrasound systems and software specifically designed to assist radiologists in the detection of breast cancer, particularly in women with dense breast tissue. The company’s innovative breast ultrasound systems produce 3D images that enhance visualization of targeted areas of concern within the breast. In addition to its focus on breast cancer diagnostics, U-Systems also designs and manufactures high-quality racking enclosures and cooling products aimed at reducing noise, heat, and costs in data centers and offices, utilizing innovative design principles and state-of-the-art manufacturing processes.

C8 MediSensors

Series C in 2012
C8 MediSensors, Inc., a San Jose, CA-based developer of non-invasive continuous glucose monitors for diabetic patients.

XPRO Sistemas

Acquisition in 2012
Xpro (Brazil) specializes in the manufacturing of medical devices, focusing primarily on X-ray equipment and angiography systems. The company is involved in the development and servicing of these medical technologies, providing essential tools for diagnostic imaging and interventional procedures in healthcare settings. By combining innovation with a commitment to quality, Xpro aims to support the medical community in enhancing patient care through advanced imaging solutions.

SeqWright

Acquisition in 2012
SeqWright, Inc., established in 1994, is a full-service contract research organization specializing in nucleic acid technology, particularly in traditional and next-generation sequencing. The company is CLIA certified and GLP compliant, allowing it to support product regulatory submissions with its comprehensive services. With over 17 years of experience in genomics, SeqWright has gained a reputation for its quality and technical expertise, as well as its ability to customize services to meet the specific needs of its clients. The company provides genomic research services, including clinical trial support for the pharmaceutical industry and genomics services for the USDA, contributing to scientific and medical innovation by facilitating and accelerating research and development efforts.

Xcellerex

Acquisition in 2012
Xcellerex is a biomanufacturing technology provider based in Marlborough, Massachusetts, founded in 2002 by Parrish M. Galliher. The company specializes in the development and production of innovative biomanufacturing systems and production-scale bioreactors that enhance the efficiency and cost-effectiveness of producing therapeutic proteins, including biosimilars and vaccines. Xcellerex's proprietary solutions, including the FlexFactory®, feature modular and portable production trains utilizing single-use technologies, advanced process automation, and compact cleanroom designs, offering advantages such as faster installation, lower capital investment, and reduced risk of cross-contamination. The company also offers contract services for process development and manufacturing of biopharmaceuticals, including its PDMax platform for process optimization and the development of vaccines, such as an inactivated virus vaccine for yellow fever.

NanoString Technologies

Series D in 2011
NanoString Technologies provides life science tools for translational research and molecular diagnostics. It offers the nCounter Analysis System, featuring automated liquid handling and digital detection, along with customizable assays and software for data analysis. The company also develops spatial genomics systems like GeoMx DSP and Hyb & Seq. Its products enable various applications in basic research, translational medicine, and diagnostics.

SerphyDose

Acquisition in 2011
SerphyDose is designs and develops software solutions for medical imagery.

Applied Precision

Acquisition in 2011
Applied Precision, Inc. provides imaging, measurement, and analysis systems for the life sciences industries and OEM markets. The company offers microscopy imaging solutions to help scientists address disease-related questions for cellular and sub-cellular analyses. Its products include DeltaVision OMX Imaging System, a microscope system that offers super-resolution imaging using 3D structured illumination and localization microscopy techniques; DV Elite, a live cell microscopy imaging system that is designed to enhance the ability to look at more probes and samples over longer periods of time; and PersonalDV, an integrated hardware/software solution for live cell research needs. The company... Detailed Description

Steady State Imaging

Acquisition in 2011
Developer of an imaging processing software. The company develops magnetic resonance imaging (MRI) data acquisition and imaging processing software packages.

Clarient

Acquisition in 2010
Clarient is a prominent provider of cancer diagnostic testing services, specializing in anatomic pathology and molecular testing. The company collaborates with local pathologists and oncologists to enhance the standard of care within their communities. By employing advanced technologies, Clarient assists healthcare professionals in accurately diagnosing cancer cases and provides valuable insights into effective therapies for patients. Additionally, the company offers consultative and commercial services tailored to biopharmaceutical companies and research organizations, as well as hematopathology testing specifically for leukemia and lymphoma. Through its comprehensive offerings, Clarient is committed to delivering clarity in complex diagnostic challenges and ensuring ongoing case monitoring and follow-up.

MedPlexus

Acquisition in 2010
As of March 24, 2010 MedPlexus, Inc. was acquired by GE Healthcare Ltd. MedPlexus, Inc. develops administrative, financial, and clinical software for the medical practices marketplace. It offers MedPlexus Practice Management system that enables users to know what is going on with the money in their practice; and MedPlexus EHR, an electronic health record system, which enables users to document the clinical visit, as well as provides health maintenance tools consisting of alerts and reminders for general health and disease management. The company also provides MedPlexus Revenue Cycle Management solutions that enables users to identify leaks in their revenue stream by reporting information.

Living Independently Group

Acquisition in 2009
Living Independently Group, Inc. is a company specializing in telecare and passive monitoring systems designed to assist in the care of seniors. Founded in 2002 and headquartered in New York, it offers QuietCare, a sophisticated passive monitoring system that employs wireless sensors to discreetly track daily activities of seniors in various environments, including assisted living centers and private homes. This system alerts caregivers to unusual activity patterns and behavioral changes, enabling timely interventions to address potential health issues before they escalate into emergencies. Living Independently Group operates primarily in the United States and the United Kingdom, and as of December 2009, it functions as a subsidiary of GE Healthcare Ltd.

ONI Medical Systems

Acquisition in 2009
ONI Medical Systems, Inc. is a developer of advanced magnetic resonance imaging systems, focusing on innovative solutions for healthcare providers. Its flagship product, MSK-Extreme, is a specialized musculoskeletal extremity scanner designed to capture detailed images of the hand, wrist, elbow, foot, ankle, and knee. The company primarily serves hospitals, imaging centers, and orthopedic practices across the United States and Canada, while also extending its reach through distribution partners in various countries, including those in Europe and South America. By providing cutting-edge imaging technology, ONI Medical Systems enhances diagnostic capabilities and improves patient care in the realm of musculoskeletal health.

Agility Healthcare Solutions

Acquisition in 2008
Agility Healthcare Solutions, established in 2002 and headquartered in Glen Allen, Virginia, specializes in delivering RFID-enabled workflow management solutions tailored for the healthcare sector. The company's offerings include real-time location system technology applications designed to monitor the physical locations of patients, assets, and staff within hospitals. Key products encompass AgileTrac Access for tracking mobile assets, AgileTrac Asset Manager for monitoring asset usage and status, and AgileTrac Patient Flow for managing patient movement through facilities. Additionally, Agility Healthcare Solutions provides AgileTrac Bed Manager for automating bed management processes, AgileTrac ED for enhancing emergency department operations, and AgileTrac Surgical Services for tracking surgical patients and resources.

VersaMed Medical Systems

Acquisition in 2008
VersaMed Medical Systems is designs, manufactures, and sells software-based mechanical ventilators for healthcare service providers.

EKR Therapeutics

Debt Financing in 2008
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products specifically tailored for oncology supportive care and various acute-care hospital needs. EKR Therapeutics focuses on addressing a range of medical issues, including oral mucositis, stomatitis, dry mouth, nutritional challenges, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea. By providing effective treatment options, EKR Therapeutics aims to enhance the quality of life for cancer patients and those experiencing acute medical conditions.

Whatman - Part of GE Healthcare

Acquisition in 2008
Whatman plc is a GE Healthcare Life Sciences brand specialising in laboratory filtration products and separation technologies. Whatman products cover a range of laboratory applications that require filtration, sample collection (cards and kits), blotting, lateral flow components and flow-through assays and other general laboratory accessories.

Dynamic Imaging

Acquisition in 2007
Dynamic Imaging is on the forefront of image and information management, bringing affordable filmless and paperless radiology to all members of the imaging community. Dynamic Imaging continues to set new standards through its innovative Web-based PACS, Web-based unified RIS/PACS solution for ambulatory practices (RIS, PACS, billing, document management), intelligent applications, and state-of-the-art workflow tools for all care settings. Dynamic Imaging's solutions are used in more than 600 sites worldwide by customers including academic and community-based acute care health care institutions, integrated delivery networks, and imaging centers and radiology group practices of all sizes.

Optherion

Series A in 2007
Optherion is a biotechnology company focused on developing diagnostic tools and disease-modifying therapies for early-stage age-related macular degeneration and other chronic diseases involving the alternative complement cascade, including dense deposit disease and atypical hemolytic uremic syndrome. Founded in 2005 and based in New Haven, Connecticut, the company aims to advance patient care by applying targeted research to identify genes linked to renal diseases and translate these insights into diagnostics and therapeutics.

CASI Pharmaceuticals

Post in 2007
CASI Pharmaceuticals, Inc. is a U.S.-based biopharmaceutical company dedicated to developing and commercializing innovative therapeutics, particularly in the fields of hematology and oncology. The company focuses on addressing unmet medical needs by acquiring and launching products in China, the United States, and globally. CASI's product portfolio includes several therapeutics, such as EVOMELA, which is used as a conditioning treatment prior to autologous stem cell transplants for multiple myeloma patients, along with CID-103, CNCT19, MARQIBO, ZEVALIN, and ENMD-2076. The company's primary revenue driver is the sales of EVOMELA, as it executes its strategy to become a leading biopharmaceutical player by leveraging its expertise in regulatory and commercial operations within the China market.

Wave Biotech

Acquisition in 2007
Wave Biotech is a research-based company, develops and manufactures process equipment for the pharmaceutical and biotechnology industry.

SpinalMotion

Funding Round in 2007
SpinalMotion is a private company focused on preserving spinal motion for patients suffering from degenerative disc disease. Founded in 2004, the company specializes in the development of innovative artificial disc implants that utilize proprietary Kineflex Technology, designed to maintain the natural movement of the spine while offering low wear and improved longevity. Since obtaining FDA approval in 2005 to conduct clinical trials for lumbar and cervical artificial discs in the United States, SpinalMotion has built on its international clinical experience to enhance patient outcomes. The company has attracted investment from notable partners, including Southern Medical, Three Arch Partners, Skyline Ventures, and MedVenture Associates, to further its mission of enabling patients to lead pain-free and healthy lives.

Idx Systems

Acquisition in 2005
IDX Systems is a provider of information technology solutions focused on enhancing the delivery of healthcare. Established in 1969 by Robert Hoehl, Richard Tarrant, and Paul Egerman, the company specializes in software services tailored for healthcare organizations. Its offerings include revenue cycle management systems, financial management software, and radiology information systems, among other business software designed to support hospitals and large physician group practices. Through its innovative technology, IDX Systems aims to maximize value in healthcare operations and improve overall efficiency within the industry.

MEDIMEX GmbH

Acquisition in 2004
MEDIMEX GmbH & Co is engages in surgical instruments and operating room accessories distribution businesses.

Amersham Health

Acquisition in 2003
Amersham, headquartered in England, is a world leader in medical diagnostics and life sciences. The Amersham Group employs over 10,000 people worldwide and had sales of GBP1.62 billion ($2.43 billion) in 2002. The company was formed in 1997 through the mergers of Amersham International (UK), Pharmacia Biotech (Sweden) and Nycomed (Norway). Amersham has three main business areas: medical diagnostics, operating as Amersham Health, and protein separations and discovery systems, together operating as Amersham Biosciences. -- Amersham Health (59 percent of total Amersham sales in 2002) develops, manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for all imaging modalities that are used in medical imaging procedures. These diagnostic agents enhance and enable the imaging of anatomy, organs, tissue and cells to assist with the early detection, diagnosis and management of diseases. Key products include the imaging agents OmnipaqueTM, MyoviewTM, OmniscanTM and VisipaqueTM; -- Protein separations (17 percent of total Amersham sales in 2002) develops, manufactures and distributes chromatography purification systems, membrane products and reagents that are used in the development and manufacture of biopharmaceuticals and for the laboratory scale separation of proteins for research and drug development; and -- Discovery systems (24 percent of total Amersham sales in 2002) develops, manufactures and distributes instruments, reagents and software that are used for drug discovery, research and development with applications including protein and DNA analysis for genomics and proteomics, cellular screening and bioassays.

Ambassador Medical

Acquisition in 2003
Ambassador Medical is engages in selling and refurbishing pre-owned ultrasound systems, parts, and transducers.

Inverness Medical

Debt Financing in 2002
Inverness Medical (now known as Alere Inc.) is a global provider of advanced consumer and professional medical diagnostic products for a range of disease states and conditions.  The company develops new capabilities in diagnosis, monitoring, and health management for sectors such as cardiovascular, respiratory, diabetes, toxicology, autoimmunity, clinical, women’s health, and more. Additionally, Inverness Medical offers services for chronic care, wellness, case management, women’s health, home monitoring, research, evaluation, and training. Since 2005, Inverness Medical has acquired nearly 20 companies, collectively creating the largest product portfolio in the industry. Inverness Medical is headquartered in Waltham, Massachusetts, USA.

InSightec

Venture Round in 2001
InSightec Ltd. is a pioneering company based in Tirat Carmel, Israel, specializing in non-invasive medical treatments through its Exablate platform, which employs MR guided focused ultrasound technology. Founded in 1999, InSightec develops and distributes systems that address various oncology and gynecology conditions, including the Exablate Neuro for personalized thalamotomy in movement disorders and pain management. The Exablate system has received multiple regulatory approvals, including CE marks and FDA approval, for treatments of symptomatic uterine fibroids, pain from bone metastases, and adenomyosis. The company provides comprehensive support services, including onsite clinical training and maintenance, to medical professionals using its technology in facilities across Israel and internationally. InSightec maintains a strategic partnership with Lantheus Holdings and has expanded its presence in Europe, Asia, and the Americas, earning recognition for its innovative contributions to the field of acoustic surgery.

Kretztechnik

Acquisition in 2001
Kretztechnik is an Austrian-based innovator in 3D Ultrasound systems. Kretztechnik AG manufactures, and sells ultrasonic diagnostic imaging equipment primarily in Austria.

Data Critical

Acquisition in 2001
Data Critical Corporation specializes in the development of communication and information systems that leverage wireless and internet technology to enhance healthcare delivery. The company's proprietary software facilitates access to vital health information, including patient vital signs and diagnostic data, enabling healthcare professionals to retrieve critical information from both remote and hospital environments. By focusing on quick turnaround solutions and personalized service, Data Critical aims to improve the efficiency and effectiveness of telemedicine for healthcare providers.

GE Imatron

Acquisition in 2001
GE Imatron manufactures electron beam tomography scanners, which use electron beam tomography technology.

Coincidence Technologies

Acquisition in 2001
Coincidence Technologies is a company that develops and manufactures chemical systems.

GE Medical Systems Oxford Magnets

Acquisition in 2000
GE Medical Systems Oxford Magnets is develops and manufactures magnets used in magnetic resonance imaging equipment.

GE Medical Systems Lunar

Acquisition in 2000
GE Medical Systems Lunar is engaged in the development and sale of x-ray and ultrasound bone densitometers.

Applicare Medical Imaging

Acquisition in 1999
Applicare Medical Imaging provides medical imaging, teleradiology, and PACS solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.